Evogene Ltd. (EVGN) stock

EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30

$0.36−0.03 (-8.70%)

Close on Nov 12, 2026Market cap $3.15MP/E 0.3Yield –

Evogene total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Evogene has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EVGN.

Revenue growth-30.9% · median 2.7%

Gross margin-6.3% · median 16.8%

Operating margin-364.2% · median -354.1%

Net margin-220.2% · median -439.3%

Advertisement
300 × 250

See a number that looks wrong?